Basel, CH-4057, Switzerland
Phone: +4161- 6924461
Jain PharmaBiotech was formed to conduct research, provide consulting services, and publish strategic reports for the pharmaceutical and biotechnology industries. Consultations performed include a variety of assignments from various companies, which include technology assessment, competitive intelligence, market analysis, design of clinical trials and finding innovative solutions for problems.
O Research and documentation of various biotechnologies: genomics, proteomics, molecular diagnostics, nanobiotechnology, RNA interference.
O Integration of biotechnologies for development of personalized medicine
O Research in gene therapy of brain tumors:preclinical investigation of destruction of glioblastoma multiforme by genetically modified bacteria.
O Planning and protocols of clinical trials of drugs for neurological disorders.
O Publication of reports on biotechnology, which are constantly updated. Current topics include:
-Alzheimers disease: new Drugs, markets, and companies
-Animal Biotechnology: technologies, markets & companies
-Antiviral Therapeutics: technologies, markets & companies.
-Biomarkers: technologies, markets and companies
-Cardiovascular Drug Delivery
-Cell therapy: technologies, markets and companies
-Cytogenetics: technologies, markets and companies
-Drug Delivery in Cancer:technologies,markets &companies
-Drug Delivery in Disorders of the Central Nervous System
-Gene therapy: technologies, markets & companies
-Molecular diagnostics: technologies, markets &companies
-Nanobiotechnology: applications, markets and companies
-Neuroprotection: drugs, markets & companies
-Nitric Oxide: therapeutics, markets & companies
-Pain Therapeutics: drugs, markets & companies
-Personalized Medicine: scientific & commercial aspects
-Proteomics: technologies, markets &companies
-RNAi: technologies, markets &companies
-Transdermal Drug Delivery
Web site: : http://www.pharmabiotech.ch
Ontact: Prof. Dr. med. K. K. Jain